Condition
Primary Sjogren Syndrome
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (1)
P 4 (2)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07153276Phase 4Recruiting
TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE
NCT02962895Phase 2CompletedPrimary
Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
NCT02004067Phase 4CompletedPrimary
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
NCT02066896Not ApplicableCompleted
Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome
Showing all 4 trials